BVXV - Biondvax Pharmaceuticals GAAP EPS of -$0.01 beats by $3.42
2023-04-18 02:34:59 ET
- Biondvax Pharmaceuticals press release ( NASDAQ: BVXV ): FY GAAP EPS of -$0.01 beats by $3.42 .
- As of December 31, 2022, BiondVax had cash and cash equivalents of $14 million as compared to $17.3 million as of December 31, 2021.
For further details see:
Biondvax Pharmaceuticals GAAP EPS of -$0.01 beats by $3.42